Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 8
Submit an article Journal homepage
16,937
Views
8
CrossRef citations to date
0
Altmetric
Review

Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL

Zachary J. RobertsKite Pharma, Santa Monica, CA, USA;
,
Marc BetterKite Pharma, Santa Monica, CA, USA;
,
Adrian BotKite Pharma, Santa Monica, CA, USA;
,
Margo R. RobertsKite Pharma, Santa Monica, CA, USA;
&
Antoni RibasDepartment of Medicine, University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USACorrespondence[email protected]
Pages 1785-1796 | Received 02 Jun 2017, Accepted 26 Sep 2017, Published online: 23 Oct 2017
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (5.6 MB)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.